Annovis Bio's total assets for Q3 2024 were $14.36M, an increase of 184.59% from the previous quarter. ANVS total liabilities were $7.30M for the fiscal quarter, a 7.36% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.